NCT02835989 (CP@Home) is a NA clinical trial of CP@Home in Cardiovascular Disease, sponsored by McMaster University.

Who is sponsoring NCT02835989?

NCT02835989 is sponsored by McMaster University.

What drugs are being tested in NCT02835989?

Interventions in NCT02835989: CP@Home.

What condition does NCT02835989 study?

NCT02835989 studies Cardiovascular Disease, Diabetes Mellitus, Accidental Falls, Social Isolation, Food Insecurity.

Is NCT02835989 still recruiting?

NCT02835989 is currently completed. Last updated 22 September 2022.

Last reviewed 2022-09-22 · How we verify

NCT02835989: CP@Home

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Community Paramedicine at Home

Completed NA Last updated 22 September 2022

What this trial tests

NA trial testing CP@Home in Cardiovascular Disease in 2,826 participants. Completed in 31 December 2021.

Timeline

25 October 2018

Primary endpoint
20 July 2020

31 December 2021

Quick facts

Lead sponsor	McMaster University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	prevention
Enrollment	2,826
Start date	25 October 2018
Primary completion	20 July 2020
Estimated completion	31 December 2021
Sites	1 location across Canada

Drugs / interventions tested

CP@Home

Conditions studied

Cardiovascular Disease — all drugs for Cardiovascular Disease →
Diabetes Mellitus — all drugs for Diabetes Mellitus →
Accidental Falls — all drugs for Accidental Falls →
Social Isolation — all drugs for Social Isolation →

Sponsor

McMaster University

Who can join

18 and older, any sex, with Cardiovascular Disease or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Community Paramedicine @Home (CP@Home) is a novel community paramedicine health assessment program for high users of Emergency Medical Services (EMS). Individuals who have been identified as active callers to EMS, individuals who have called EMS for lift-assists, and direct paramedic referrals are referred into the community paramedicine home visit program. The program will focus on in-home chronic disease management, community health service connections, and EMS usage education. Aside from chronic disease management, aspects of the program include health-related quality of life, social isolation and other social determinants of health. Participants in the program will have up to 3 one-on-one home visits from a community paramedic to ultimately reduce repeat EMS calls and improve their overall health.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Rationale and methods of an Evaluation of the Effectiveness of the Community Paramedicine at Home (CP@home) program for frequent users of emergency medical services in multiple Ontario regions: a study protocol for a randomized controlled trial.
Agarwal G, Pirrie M, McLeod B, Angeles R, et al · · 2019 · cited 8× · PMID 30674347 · DOI 10.1186/s13063-018-3107-4
Effectiveness of the community paramedicine at home (CP@home) program for frequent users of emergency medical services in Ontario: a randomized controlled trial.
Agarwal G, Angeles R, Brar J, Pirrie M, et al · · 2024 · cited 2× · PMID 39587610 · DOI 10.1186/s12913-024-11952-7

Verify or expand the search:

Other recruiting trials for Cardiovascular Disease

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07293260 — Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial · Phase 3 · recruiting
NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
NCT06625073 — Randomized Trial of SGLT2i in Heart Transplant Recipients · Phase 4 · recruiting
NCT06485700 — Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A) · NA · recruiting

Other McMaster University trials

Trials by the same sponsor.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02835989 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McMaster University
Last refreshed: 22 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02835989.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing